The US Food and Drug Administration (FDA) has approved the first artificial
For example, it will be useful for valvular disease(valvular heart disease) - it occurs when the valves of the heart do not function properly, affecting blood circulation and the flow of blood into the chambers of the heart, because the valves do not open or close properly.
According to the Center for Control and Preventiondiseases, about 2.5% of the US population suffer from valvular disease. Tens of thousands of people die every year from complications such as heart failure or cardiac arrest.
It is difficult to identify this disease - a doctor needsmonitor the patient's heartbeat and be able to recognize an unusual sound or pattern, as well as determine which valve is abnormal and what problem it is causing. Determining whether the sound and pattern of the heartbeat is irregular can be subjective, meaning the condition is often misdiagnosed or missed altogether.
This is where algorithms can come in handy.artificial intelligence. Eko, a digital health startup based in Oakland, California, has developed software to analyze heartbeats and help healthcare professionals identify heart murmurs. Eko Murmur Analysis Software (EMAS) is the first of its kind to receive FDA approval.
Heartbeat data collected by physiciansusing Eko intelligent stethoscopes are analyzed by EMAS. EMAS characterizes heart murmurs to determine in seconds and better understand what type of heart disease a patient may have.
Read more:
The oldest Voyager 1 mission has a strange glitch that cannot be fixed
The James Webb telescope took the first picture of Jupiter: it shows 9 moving targets at once
Scientists have found a "Pandora's box" in the bowels of the Earth: the energy from there feeds life on the planet